While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.
Justin Zamirowski
Advertisement
Articles by Justin Zamirowski
While COVID-19 has shifted the rules of the healthcare industry, research shows there was already progress on changes being made for how pharma companies are launching products.
Advertisement
Latest Updated Articles
- New Standards for First-to-Launch Players
September 14th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
2
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
3
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5